首页> 外国专利> NEUROTOXIC TARGET FOR AMYLOSPHEROID, METHOD AND MATERIAL FOR REDUCING THE NEUROTOXICITY OF AMYLOSPHEROID, AND USE THEREOF

NEUROTOXIC TARGET FOR AMYLOSPHEROID, METHOD AND MATERIAL FOR REDUCING THE NEUROTOXICITY OF AMYLOSPHEROID, AND USE THEREOF

机译:拟南芥的神经毒性靶标,降低拟南芥神经毒性的方法和材料及其用途

摘要

In one or a plurality of embodiments, there is provided a target molecule of amylospheroid, which is expressed in mature neurons and to which the amylospheroid binds to induce death of cells. Further, in one or a plurality of embodiments, there is provided a method and a substance for inhibiting death of mature neurons induced by the amylospheroid. In one aspect, the present disclosure relates to a use of Na+/K+-ATPase α3 as a binding target molecule of amylospheroid. In another aspect, the present disclosure relates to a method for suppressing death of mature neurons induced by the amylospheroid, including inhibiting protein-protein interaction between the amylospheroid and the Na+/K+-ATPase α3, and the like.
机译:在一个或多个实施方案中,提供了一种淀粉样球蛋白的靶分子,其在成熟的神经元中表达,并且该淀粉样球蛋白与之结合以诱导细胞死亡。此外,在一个或多个实施方式中,提供了一种抑制由淀粉样球蛋白诱导的成熟神经元死亡的方法和物质。一方面,本发明涉及Na + / K + -ATPaseα3作为淀粉样球蛋白的结合靶分子的用途。另一方面,本发明涉及一种抑制由淀粉样球蛋白诱导的成熟神经元死亡的方法,包括抑制淀粉样球蛋白与Na + / K + -ATPaseα3等。

著录项

  • 公开/公告号US2013171069A1

    专利类型

  • 公开/公告日2013-07-04

    原文格式PDF

  • 申请/专利权人 TAO HEALTH LIFE PHARMA CO. LTD.;

    申请/专利号US201213729152

  • 发明设计人 MINAKO HOSHI;

    申请日2012-12-28

  • 分类号C07K5/117;A61K38/17;A61K38/13;C07K5/107;G01N33/68;C07K7/06;C07K7/08;A61K51/08;A61K31/554;

  • 国家 US

  • 入库时间 2022-08-21 16:49:06

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号